1 Department of Cardiology Japanese Red Cross Ashikaga Hospital Ashikaga Japan.
2 Duke Clinical Research Institute Duke University Medical Center Durham NC.
J Am Heart Assoc. 2019 Mar 5;8(5):e011183. doi: 10.1161/JAHA.118.011017.
Background Scarce data exist about the outcomes after percutaneous coronary intervention ( PCI ) in old patients. This study sought to provide an overview of PCI in elderly patients, especially nonagenarians, in a Japanese large prospective nationwide registry. Methods and Results We analyzed 562 640 patients undergoing PCI (≥60 years of age) from 1018 Japanese hospitals between 2014 and 2016 in the J-PCI (Japanese percutaneous coronary intervention) registry. Among them, 10 628 patients (1.9%), including 6780 (1.2%) with acute coronary syndrome ( ACS ) and 3848 (0.7%) with stable coronary artery disease, were ≥90 years of age. We investigated differences in characteristics and in-hospital outcomes among sexagenarians, septuagenarians, octogenarians, and nonagenarians. Older patients were more frequently women and had a greater frequency of heart failure and chronic kidney disease than younger patients. In addition, older patients had a higher rate of in-hospital mortality, cardiac tamponade, cardiogenic shock after PCI , and bleeding complications requiring blood transfusion. Nonagenarians had the highest risk of in-hospital mortality (odds ratio, 3.60; 95% CI , 3.10-4.18 in ACS ; odds ratio , 6.24; 95% CI, 3.82-10.20 in non- ACS ) and bleeding complications ( odds ratio, 1.79; 95% CI, 1.35-2.36 in ACS ; odds ratio , 2.70; 95% CI, 1.68-4.35 in non- ACS ) when referenced to sexagenarians. More important, transradial intervention was an inverse independent predictor of both in-hospital mortality and bleeding complications. Conclusions Older patients, especially nonagenarians, carried a greater risk of in-hospital death and bleeding compared with younger patients after PCI . Transradial intervention might contribute to risk reduction for periprocedural complications in elderly patients undergoing PCI .
关于老年患者(≥60 岁)经皮冠状动脉介入治疗(PCI)后的结局数据十分有限。本研究旨在通过日本一项大型前瞻性全国注册研究,提供老年患者(尤其是≥90 岁高龄患者)PCI 治疗的概况。
我们分析了 2014 年至 2016 年期间日本 1018 家医院共 562640 例行 PCI(≥60 岁)患者的临床资料。其中,10628 例(1.9%)患者年龄≥90 岁,包括急性冠状动脉综合征(ACS)患者 6780 例(1.2%)和稳定型冠状动脉疾病患者 3848 例(0.7%)。我们调查了不同年龄组(60-69 岁、70-79 岁、80-89 岁和≥90 岁)之间的特征和住院结局差异。与年轻患者相比,高龄患者更多为女性,心力衰竭和慢性肾脏病的发生率更高。此外,高龄患者住院期间死亡率、心脏压塞、PCI 后心源性休克和需要输血的出血并发症发生率更高。与 60-69 岁患者相比,非 90 岁高龄患者住院期间死亡率(ACS:优势比[OR]3.60,95%置信区间[CI]3.10-4.18;非 ACS:OR 6.24,95%CI 3.82-10.20)和出血并发症(ACS:OR 1.79,95%CI 1.35-2.36;非 ACS:OR 2.70,95%CI 1.68-4.35)风险更高。更重要的是,经桡动脉介入治疗是 PCI 后住院死亡率和出血并发症的独立负向预测因素。
与年轻患者相比,老年患者(尤其是≥90 岁高龄患者)PCI 后住院期间死亡和出血风险更高。经桡动脉介入治疗可能有助于降低老年 PCI 患者围术期并发症风险。